Opening Remarks, Presidential & Program Chair Welcome
8:30 AM - 9:30 AM
General Session 1
Moderator:
Gweneth B. Lazenby (Medical University of South Carolina)
8:30 AM - 9:15 AM
Clinical and Pathological Features of Septic Abortion
Speaker:
David M. Aronoff, MD, FIDSA, FAAM (Indiana University School of Medicine)
9:15 AM - 9:30 AM
Q&A
Speaker:
David M. Aronoff, MD, FIDSA, FAAM (Indiana University School of Medicine)
9:30 AM - 10:15 AM
Oral Abstract Session 1
Moderators:
Chelsea Elwood (University of British Columbia) & Kristen Warncke (University of Texas Southwestern Medical Center)
9:30 AM - 9:45 AM
Population Pharmacokinetics of Sofosbuvir/Velpatasvir in Pregnant Women with Hepatitis C Virus (#001)
Speaker:
Riley Randolph (University of Colorado Anschutz Medical Campus)
9:45 AM - 10:00 AM
The Effect of HCV on Methadone Dose During Pregnancy (#002)
Speaker:
Sarah Boudova (Thomas Jefferson University)
10:00 AM - 10:15 AM
Hepatitis C Virus Infection Across Multiple Pregnancies, Surveillance for Emerging Threats to Pregnant Persons and Infants Network – 2018-2021 (#003)
Speaker:
Suzanne Newton (Centers for Disease Control and Prevention)
10:15 AM - 10:30 AM
Break
10:30 AM - 11:30 AM
Oral Abstract Session 2
Moderators:
Sarah Boudova (Thomas Jefferson University) & Andrés Ramírez Zamudio (Icahn School of Medicine at Mount Sinai)
10:30 AM - 10:45 AM
Pregnancy Characteristics and Birth Outcomes in People with Mpox Infection During Pregnancy – Surveillance for Emerging Threats to Pregnant People and Infants Network (#004)
Speaker:
Varsha Neelam (Centers for Disease Control and Prevention)
10:45 AM - 11:00 AM
Geographic Distribution and Characteristics of Inadequate Maternal Syphilis Treatment (#005)
Speaker:
Kristen Warncke (University of Texas Southwestern Medical Center)
11:00 AM - 11:15 AM
Universal Prenatal Screening for Chagas Disease in an At-Risk Population (#006)
Speaker:
Barbara Neuhoff (University of Texas Health Science Center at San Antonio (UTHSCSA))
11:15 AM - 11:30 AM
Increased Uptake of Intermittent Preventive Treatment for Prevention of Malaria in Pregnancy and Scale-Up of Group Antenatal Care in Nasarawa State, Nigeria (#007)
Speaker:
Lisa Noguchi (Johns Hopkins Bloomberg School of Public Health)
11:30 AM - 12:15 PM
Stump the Professors
Speaker:
Sarah Boudova (Thomas Jefferson University)
Moderators:
David M. Aronoff, MD, FIDSA, FAAM (Indiana University School of Medicine), Jennifer Balkus, PhD, MPH (University of Washington, Seattle, WA), Catherine Chappell, MD, MSc (Magee-Womens Hospital of UPMC) & Patrick Ramsey, MD, MSPH (University of Texas Health Sciences Center at San Antonio)
12:15 PM - 12:45 PM
Break
12:45 PM - 1:45 PM
Industry Sponsored Symposium
1:45 PM - 2:45 PM
Poster Session 1
Revealing Mechanisms of Female Sexual Dysfunction Through Multi-Omics Analysis of the Vaginal Microenvironment (#022)
COVID-19 Maternal Antibody Concentrations in Small for Gestational Age Infants: Does Placental Insufficiency Impact Transplacental Antibody Transfer? (#032)
Speaker:
Alisa Kachikis (University of Washington Department of Obstetrics & Gynecology)
Alinity m HR HPV Investigational Use Only (IUO) Assay: Designed to Meet US Guidelines for Managing Patients in Cervical Cancer Screening Programs (#036)
Speaker:
Josh Kostera (Abbott Laboratories)
Maternal Outcomes of Parvovirus B19 Infections in Pregnancy (#037)
Speaker:
Jennifer Okunbor (Duke University School of Medicine)
Gonococcal Endocarditis, a Life-Threatening Complication of a "Screenable" Infection
Speakers:
Denise Ornelas (University of California, Riverside, School of Medicine) & Diana Ornelas (University of California, Riverside, School of Medicine)
Moderator:
Gweneth B. Lazenby (Medical University of South Carolina)
8:15 AM - 9:00 AM
Breastfeeding in people with HIV: Where have we been and where are we going?
Speaker:
Lisa Rahangdale, MD, MPH (UNC School of Medicine)
9:00 AM - 9:15 AM
Q&A
Speaker:
Lisa Rahangdale, MD, MPH (UNC School of Medicine)
9:15 AM - 10:15 AM
Oral Abstract Session 3
Moderators:
Gweneth B. Lazenby (Medical University of South Carolina) & Anna Powell (Johns Hopkins School of Medicine)
9:15 AM - 9:30 AM
Determining the Pharmacokinetics of Azithromycin in Pregnant Subjects Undergoing Cesarean Delivery After Failed Labor (#008)
Speaker:
Miriam Estin (Duke University Hospital)
9:30 AM - 9:45 AM
Secreted Proteases from Vaginal Prevotella Species Target and Mimic Human MMPs and Modulate Endocervical Barrier Function (#009)
Speaker:
Karen Lithgow (University of Calgary)
9:45 AM - 10:00 AM
Impact of Chlorhexidine and Povidone-Iodine Antiseptic Solutions on the Vaginal Microbiome in Women Undergoing Gynecologic Surgeries: a Pilot Study (#010)
Speaker:
Pawel Laniewski (University of Arizona)
10:00 AM - 10:15 AM
Gardnerella Species Variations Show Pathogenic and Metabolic Differences (#011)
Speaker:
Pita Navarro (Evvy)
10:15 AM - 10:30 AM
Break
10:30 AM - 11:15 AM
Oral Abstract Session 4
Moderators:
Amanda Adams (Harvard School of Public Health) & Alisa Kachikis (University of Washington Department of Obstetrics & Gynecology)
10:30 AM - 10:45 AM
Vaginal Microbiota Linked to HIV Acquisition Risk Are Not Associated with Changes in Concentrations of Cervical Dendritic Cells and CD4+ T Cells (#012)
Speaker:
Michelle C. Sabo (University of Washington)
Speaker:
Amanda Adams (Harvard School of Public Health)
11:00 AM - 11:15 AM
HIV Vertical Transmission and Adverse Pregnancy Outcomes among People Living with and without HIV with and without Syphilis-Co-infection in Southern Brazil, 2008-2018 (#014)
Speaker:
Lanbo Yang (Warren Alpert Medical School of Brown University)
11:15 AM - 12:15 PM
President's Forum
Speakers:
Richard Beigi, MD, MSc, Dana Meaney-Delman, MD, MPH, FACOG, Amy Murtha, MD & Laura Riley, MD
Moderator:
Geeta Swamy, MD
12:15 PM - 12:45 PM
Break
12:45 PM - 1:45 PM
Industry Sponsored Symposium
1:45 PM - 2:45 PM
Poster Session 2
Preferences for Pediatric and Perinatal HCV Screening and Treatment from Focus Group with Sex Workers. (#045)
Breast Milk Feeding Initiation among Pregnant Persons with Hepatitis C Virus Infection – Surveillance for Emerging Threats to Pregnant People and Infants Network (#057)
Feasibility of a 30-Minute Sample-to-Answer Chlamydia Trachomatis, Neisseria Gonorrhea, and Trichomonas Vaginalis Multiplex Test on a Rapid Molecular Point-of-Care System* (#060)
Moderator:
Gweneth B. Lazenby (Medical University of South Carolina)
8:45 AM - 9:30 AM
Anal Cancer Screening: What the OBGYN Needs to Know
Speaker:
Christine Conageski, MD, MSc (University of Colorado SOM)
9:30 AM - 9:45 AM
Q&A
9:45 AM - 10:45 AM
Oral Abstract Session 5
Moderators:
Gweneth B. Lazenby (Medical University of South Carolina) & Kendall Moore (Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA)
9:45 AM - 10:00 AM
Changes in Vaginal Bacteria and Inflammatory Mediators from Periconception through Early-Postpartum in a Cohort of HIV-negative Kenyan Women (#019)
Speaker:
Michelle C. Sabo (University of Washington)
10:00 AM - 10:15 AM
Analysis of Dried Blood Spot and Saliva PCR Screening for Detection of Congenital Cytomegalovirus Infection Informs Implementation of a Novel Universal Newborn Screening Program (#016)
Speaker:
Daniel Landers (University of Minnesota Medical School and M Health Fairview Health System)
10:15 AM - 10:30 AM
Association Between Glycemic Control and Group B Streptococcus Colonization Among Pregnant Individuals with Pregestational Diabetes (#017)
Speaker:
Tracy Caroline Bank (Ohio State University Wexner Medical Center)
10:30 AM - 10:45 AM
Neighborhood Socioeconomic Disadvantage and Group B Streptococcus Colonization in Pregnancy (#018)
Speaker:
Tracy Caroline Bank (Ohio State University Wexner Medical Center)
10:45 AM - 11:00 AM
Break
11:00 AM - 11:45 AM
Oral Abstract Session 6
Moderators:
Gweneth B. Lazenby (Medical University of South Carolina) & Lisa Noguchi (Johns Hopkins Bloomberg School of Public Health)
11:00 AM - 11:15 AM
Effectiveness of Maternal Influenza Vaccination During Pregnancy Against Influenza-Associated Emergency Department Visits and Hospitalizations in Infants <6 Months of Age (#015)
Speaker:
Samantha Olson (CDC)
11:15 AM - 11:30 AM
Prospective Cohort Study Examining the Association between Vaginal Washing and Neisseria gonorrhoeae Infection in Women Who Engage in Sex Work in Mombasa, Kenya (#020)
Speaker:
Stephanie McLaughlin (University of Washington)
11:30 AM - 11:45 AM
SARS-CoV-2 Infection During Pregnancy and Gene Co-expression Network Analyses of the Placental Transcriptome (#021)
Speaker:
Kendall Moore (Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA)